Jellyfish and Polyps: Cnidarians as Sustainable Resources for Biotechnological Applications and Bioprospecting - II
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 18933
Special Issue Editors
Interests: jellyfish; microalgae; blue-biotechnology; bioactive compounds; antioxidants; anticancer; nutraceuticals; marine plants; novel foods; drug discovery; gap junction intercellular communications (GJIC)
Special Issues, Collections and Topics in MDPI journals
Interests: natural bioactive compounds; toxicology; cytotoxicology; Cnidaria; drug discovery; ecotoxicology
Special Issues, Collections and Topics in MDPI journals
Interests: marine invertebrate zoology and developmental biology; cnidarian zoology and evolutionary developmental biology; integrative taxonomy; systematics; ecology; trophic ecology; genetic connectivity; marine bioinvasions; metagenomics; reverse development; cell transdifferentiation; organogenesis; bioactive compounds; biotechnological applications
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Climate change and other concurrent anthropogenic causes are influencing the frequency and abundance of jellyfish blooms, with large impacts on the structure and functioning of marine plankton ecosystems as well as on human activities in coastal zones. In parallel, sea anemones, corals, and less familiar forms of benthic polypoid cnidarians constitute a major group of suspension feeders governing energy transfer from the water column to seafloor organisms.
Their outstanding ecological importance in worldwide marine ecosystems calls for increased global monitoring of cnidarian ecology and life cycles. At the same time, many cnidarians are now regarded as potential sustainable resources, calling for new investigations into their chemical and biochemical compositions, the physical–chemical features and supramolecular organization of their protein components, the screening and identification of their bioactive molecules, their associated microbiomes, and their possible biotechnological exploitation in different fields.
The apparent vulnerability of their soft bodies, their limited swimming ability, and their wide biodiversity with about 13,400 living described species make cnidarians top candidates for the development of biochemical strategies for survival (feeding, defense) and reproduction, including symbiosis or other relationships with microbes and other organisms. Venomous compounds occurring in extracts of cnidarians are viewed with particular interest for both of the aims, as well as the mitigation of their adverse effects and their possible beneficial use for humans. Furthermore, in the pharmacopeia of traditional medicine of Eastern countries, jellyfish are regarded as a treatment for disorders and diseases and represent a valuable foodstuff with health benefits, suggesting the occurrence of bioactive compounds. Despite the increasing attention on jellyfish blooms, scientific knowledge supporting their possible utilization and exploitation is still limited.
This Special Issue will collect novel research papers and original reviews focusing on bioprospecting marine cnidarians and on the exploitation of their biomasses and derived compounds for biotechnological and biomedical applications, as well as active ingredients for pharmaceutical, nutraceutical, cosmetic, and cosmeceutical uses.
Dr. Antonella Leone
Dr. Gian Luigi Mariottini
Prof. Stefano Piraino
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- jellyfish proteins
- bioactive compounds
- biopeptides
- biodiversity
- anti-cancer
- photoprotection
- jellyfish collagen
- marine biomaterials
- jellyfish symbionts
- cosmetics and cosmeceutics
- nutraceuticals
- novel foods
- jellyfish-associated microbiome
- sustainable farming
- sustainable fishery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.